Harnessing immunity for cancer marker discovery
- 1 January 2003
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 21 (1) , 37-38
- https://doi.org/10.1038/nbt0103-37
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Fingerprinting the circulating repertoire of antibodies from cancer patientsNature Biotechnology, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Clinical proteomics: translating benchside promise into bedside realityNature Reviews Drug Discovery, 2002
- Large Scale Identification of Human Hepatocellular Carcinoma-Associated Antigens by AutoantibodiesThe Journal of Immunology, 2002
- Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigensEuropean Journal of Immunology, 2002
- Protein based microarrays: A tool for probing the proteome of cancer cells and tissuesProteomics, 2001
- Contribution of proteomics to tumor immunologyProteomics, 2001
- An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancerProceedings of the National Academy of Sciences, 2001
- A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor AntigensThe Journal of Experimental Medicine, 1998